Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Weight loss varies depending on individual factors such as starting weight, adherence to the treatment plan, and lifestyle choices
Gastrointestinal symptoms are the most frequent side effects, affecting approximately 40% of patients during the initial titration phase
World J Diabetes 16(7): 107406
If you're of childbearing potential, discuss contraception, as Zepbound is not recommended during pregnancy
Clinical trials and real-world studies consistently show that gastrointestinal symptomsnausea, vomiting, diarrhea and constipationare the most common side effects of GLP-1 receptor agonists.Harvard Health+3Nature+3PMC+3 In obesity trials in particular, constipation often shows up more frequently than it does in type 2 diabetes trials.Taylor & Francis Online+1 As a nutritionist who works every day with people struggling with IBS, chronic constipation, bloating and other functional digestive issues, Im seeing more and more clients who are also using GLP-1 medications
If you are starting a weight loss program that includes semaglutide, your doctor may want to check your INR more frequently during the first few weeks to ensure your levels stay within the target range
